Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2012
11/15/2012WO2012154340A1 Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients
11/15/2012WO2012154249A1 Substituted aminobutyric derivatives as neprilysin inhibitors
11/15/2012WO2012153950A2 Method for preparing t-butyl 2-((4r,6s)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012WO2012152953A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
11/15/2012WO2012151701A1 Methods for the treatment and diagnostic of pulmonary arterial hypertension
11/15/2012WO2012128582A3 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
11/15/2012WO2012109065A9 Treatment and prevention of cardiovascular disease and thrombosis
11/15/2012WO2012099770A3 Diazeniumdiolate derivatives
11/15/2012US20120289932 Device and method for combining a treatment agent and a gel
11/15/2012US20120289614 Functionalized biodegradable triclosan monomers and oligomers for controlled release
11/15/2012US20120289593 Methods for risk assessment, treating, and diagnosing myocardial infarction
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289586 SDF-1 Delivery For Treating Ischemic Tissue
11/15/2012US20120289585 SDF-1 Delivery For Treating Ischemic Tissue
11/15/2012US20120289583 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/15/2012US20120289573 Methods for treatment with bucindolol based on genetic targeting
11/15/2012US20120289554 4-dimethylaminobutyric acid derivatives
11/15/2012US20120289553 Oral liquid pharmaceutical composition of nifedipine
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289549 New hexahydropyrroloimidazolone compounds
11/15/2012US20120289542 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
11/15/2012US20120289540 Kinase inhibitors useful for the treatment of proliferative diseases
11/15/2012US20120289528 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
11/15/2012US20120289521 Treatment of Acne and Other Diseases
11/15/2012US20120289518 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/15/2012US20120289517 Solid pharmaceutical composition for oral administration
11/15/2012US20120289512 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289503 Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012US20120289490 Compositions and methods for enhancing corticosteroid delivery
11/15/2012US20120289485 Metformin Salts of Salicylic Acid and Its Congeners
11/15/2012US20120289482 Method for modulating or controlling connexin 43(Cx43) level of a cell and reducing arrhythmic risk
11/15/2012US20120289474 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
11/15/2012US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals
11/15/2012US20120289467 Compositions and Methods Utilizing Fibrin Beta Chain Fragments
11/15/2012US20120289464 Angiogenically effective unit dose of fgf-2 and method of use
11/15/2012US20120289460 Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
11/15/2012US20120289453 Novel glp-1 compounds
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288571 Antimicrobial Agents and Methods of Use
11/15/2012US20120288569 Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
11/15/2012US20120288568 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (rbp), and/or serum retinol-rbp modulation
11/15/2012US20120288535 Rare earth nanoparticles
11/15/2012US20120288532 Multi-layered, multiple unit pharmaceutical compositions
11/15/2012US20120288530 Tissue sealants from plasma derived proteins
11/15/2012US20120288529 Pharmaceutical excipient, method for its preparation and use thereof
11/15/2012US20120288513 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
11/15/2012US20120288496 Notch-Binding Agents and Antagonists and Methods of Use Thereof
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288486 Method for Ameliorating or Preventing Arrhythmic Risk Associated with Cardiomyopathy
11/15/2012US20120288481 Treatment of heart disease
11/15/2012US20120288441 Injectable biodegradable particles
11/15/2012CA2835286A1 Carbonic anhydrase targeting agents and methods of using same
11/15/2012CA2833914A1 Methods for the treatment and diagnostic of pulmonary arterial hypertension
11/15/2012CA2831351A1 Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients
11/14/2012EP2522354A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
11/14/2012EP2522347A1 Flavonols and procyanidins for inducing peripheral blood vessel vasodilation
11/14/2012EP2521785A2 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
11/14/2012EP2521726A1 5-oxo-5, 8-dihydropyrido [2, 3-d]pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases
11/14/2012EP2521725A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
11/14/2012EP2521724A2 Agents and methods for treating ischemic and other diseases
11/14/2012EP2521565A1 Biomatrices to attract and retain regenerative and reparative cells
11/14/2012EP2521560A1 Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atherosclerosis and cardiovascular disease
11/14/2012CN1675250B Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
11/14/2012CN102781930A Novel anti-platelet agent
11/14/2012CN102781924A Selenalzole derivative having ligand which activates Peroxisome Proliferator Activated Receptor (PPAR), preparing method thereof and usage of the chemical compounds
11/14/2012CN102781464A Biomatrices to attract and retain regenerative and reparative cells
11/14/2012CN102781447A Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
11/14/2012CN102781430A Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
11/14/2012CN102776150A Method for inducing umbilical cord mesenchymal stem cells to differentiate into endothelial cells
11/14/2012CN102776129A Isaria cretacea and application thereof
11/14/2012CN102775493A IL-1beta binding antibodies and fragments thereof
11/14/2012CN102775490A Secretory protein with migration activity and application thereof
11/14/2012CN102775472A Aprotinin and analogue as carriers across the blood-brain barrier
11/14/2012CN102775460A Application of ginsenoside Rb3 in preparation of medicine for preventing and curing myocardial remodeling
11/14/2012CN102775411A Aryl ethynyl benzamide compound used as protein kinase inhibitor
11/14/2012CN102775408A Stable amorphous 5-methyltetrahydrofolate salt and preparation method thereof
11/14/2012CN102775407A Stable 5-methyltetrahydrofolate crystal form and preparation method thereof
11/14/2012CN102775389A Preparation method of N-substituted-4-(7-chloro-quinoline -4-amino)-benzamide derivatives, and application thereof
11/14/2012CN102775384A Broussone-tine I and J analogue and preparation method and applications thereof
11/14/2012CN102772775A Tablet for returning Yang and tonifying Qi
11/14/2012CN102772748A Traditional Chinese medicine preparation for treating liver-depression qi-stagnation type viral myocarditis and preparation method thereof
11/14/2012CN102772747A Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis
11/14/2012CN102772719A Health-care traditional Chinese medicine composition used for anus diseases
11/14/2012CN102772711A Medicament for treating haemorrhoids and preparation method thereof
11/14/2012CN102772704A Medicament for treating geriatric disease
11/14/2012CN102772689A Pear and lotus root honey ointment
11/14/2012CN102772675A Pharmaceutical composition for treating apoplexy hemiplegia and preparation method of pharmaceutical composition
11/14/2012CN102772673A Traditional Chinese medicine new medicinal composition for treating apoplexy with syndrome of wind phlegm stasis
11/14/2012CN102772668A Tablets for supplementing qi and nourishing yin
11/14/2012CN102772665A Traditional Chinese medicine preparation for treating yin deficiency and internal heat type vital myocarditis and preparation method thereof
11/14/2012CN102772653A Tablets for nourishing yin and tonifying blood
11/14/2012CN102772647A Group of tablets for restoring normal coordination between heart and kidney
11/14/2012CN102772629A Tablet for soothing nerves and relieving restlessness
11/14/2012CN102772593A Medicated wine for nourishing heart and activating brain and preventing sudden death and preparation method thereof
11/14/2012CN102772590A Traditional Chinese medicine composition, gel paste and preparation method
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 1595